Larry Grubb joins VanDeMark Chemical as VP of Global Sales & Business Development

Will spearhead market integration of VanDeMark and Framochem

VanDeMark Chemical, a supplier of phosgene to the pharmaceutical and other industries, has appointed Larry Grubb as Vice President of Global Sales & Business Development.

He will manage the sales staff of both VanDeMark and Framochem Kft, Kazincbarcika, Hungary.

VanDeMark is a North American manufacturer of phosgene and phosgene derivatives, while subsidiary Framochem is a Europe-based manufacturer of such products.

Grubb was most recently Director of Business Development for Axiall, a manufacturer of integrated chlorovinyls and vinyl-based products.

He previously held positions at PPG Industries, including General Manager of Speciality Phosgene Derivatives.

You may also like

Manufacturing

CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery

The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
Ingredients

Therapeutic: acoramidis for transthyretin amyloid cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare progressive disease that results from genetic mutations or ageing; misfolded TTR protein accumulates as amyloid fibrils in the myocardium
Ingredients

Therapeutic: lutikizumab for hidradenitis suppurativa

Hidradenitis suppurativa (HS) — also known as acne inversa — is a chronic, recurrent and progressive inflammatory disease that leads to irreversible skin damage and disability
Ingredients

Olon: celebrating 10 years of daptomycin and doubled production capacity

Olon's Daptomycin celebrates its 10th anniversary, and in the very year that marks the first decade of production of this first in a new class of antibiotics that represented a breakthrough in the treatment of skin infections, the leading API supplier group announces the doubling of its production to meet and exceed global demand for the active ingredient
Ingredients

Rousselot announces access to pure gelatins through BIO INX

Research and technical grade gelatins are now available for online purchase in Canada, Europe, South Korea and the US
Manufacturing

Exploring TiO2-free hard capsules

The quest for TiO2 alternatives underscores the unwavering commitment of the pharmaceutical industry to deliver safe and effective medicines to patients worldwide
Ingredients

C2 PHARMA announces upcoming launch of new oxybuprocaine hydrochloride API

C2 PHARMA excited to announce the upcoming launch of its new API, oxybuprocaine HCL, an ingredient that will be manufactured by manufacturing partner Laurus Labs
Subscribe now